GHK-Cu FAQ What is GHK-Cu used for in research
Professor Ania Jastreboff, MD, PhD Yale University provided an overview #ADA2026 of the TRIUMPH-1 trial for Retatrutide, the investigational triple G medicine from Eli Lilly and Company The unique trial design provided insights beyond #weightloss #obesity and also encompassed relevant endpoints for co-morbidities such as knee osteoarthritis and obstructive sleep apnea, two comorbidities highly sensitive to weight loss
This is especially concerning in patients with Neurofibromatosis type 1 (NF1) who have a pre-existing plexiform neurofibroma that suddenly changes in size or becomes painful (Evans et al., 2021)
I had a reckoning where I'm like, 'People are scrutinizing [me], and not only are they scrutinizing [me], they're verbalizing their displeasure with how I look because I don't look a certain way." While the joke in question never made it onto a script, the damage had been done
It is being studied across the Phase 3 TRIUMPH and TRANSCEND programs, which began in 2023 and have enrolled more than 5,800 participants
Common protocols are once daily for systemic recovery or twice daily (split morning and evening) when targeting a specific injury